\-\ Texto\\:\\ \ \(0\)\
\-\ well\\ developed\\,\\ well\\ nourished\\ male\ \(1\)\
\-\ raiu\\ \\=0\\.5\\%\ \(0\)\
\-\ tsh\\=\\ 0\\.016\\ uiu\\/ml\ \(0\)\
\-\ t3\\ \\=\\ 234\\ ng\\/dl\ \(0\)\
\-\ steroids\ \(152\)\
\-\ discontinue\\ use\\ of\\ amioradone\\ if\\ clinically\\ feasible\ \(0\)\
\-\ global\\ decreased\\ radiotracer\\ uptake\\ of\\ the\\ thyroid\\ gland\ \(0\)\
\-\ amioradone\\ induced\\ chemical\\ thyrotoxicosis\ \(0\)\
\-\ subacute\\ thyroditis\ \(0\)\
\-\ jod\\-basedow\\ phenomenon\ \(0\)\
\-\ factitious\\ hyperthyroidism\ \(0\)\
\-\ 66\\ year\\ old\\ male\\ with\\ changes\\ in\\ sleeping\\ pattern\\,\\ heat\\ intolerance\\ and\\ increased\\ appetite\\ treated\\ for\\ cardiac\\ arrythmias\\ with\\ amioradone\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amioradone\\:\\ 0\\.5503870083473362\ \(0\)\
\-\ 234\\:\\ 0\\.17530805650370507\ \(0\)\
\-\ thyroditis\\:\\ 0\\.17530805650370507\ \(0\)\
\-\ arrythmias\\:\\ 0\\.1695225030461018\ \(0\)\
\-\ discontinue\\:\\ 0\\.16503487914293288\ \(0\)\
\-\ feasible\\:\\ 0\\.16503487914293288\ \(0\)\
\-\ factitious\\:\\ 0\\.15826811020463682\ \(0\)\
\-\ thyrotoxicosis\\:\\ 0\\.14294076646118228\ \(0\)\
\-\ raiu\\:\\ 0\\.13715521300357905\ \(0\)\
\-\ sleeping\\:\\ 0\\.1352384368360126\ \(0\)\
\-\ global\\:\\ 0\\.13266758910041013\ \(0\)\
\-\ phenomenon\\:\\ 0\\.13187882416048963\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.12900093339150537\ \(0\)\
\-\ heat\\:\\ 0\\.12708415722393893\ \(0\)\
\-\ intolerance\\:\\ 0\\.1264837864302417\ \(0\)\
\-\ chemical\\:\\ 0\\.12478325888432151\ \(0\)\
\-\ t3\\:\\ 0\\.1242469356862874\ \(0\)\
\-\ appetite\\:\\ 0\\.1204046375680028\ \(0\)\
\-\ nourished\\:\\ 0\\.11755591421245673\ \(0\)\
\-\ induced\\:\\ 0\\.11376317076739416\ \(0\)\
\-\ well\\:\\ 0\\.11109602839753756\ \(0\)\
\-\ 66\\:\\ 0\\.10758861237596376\ \(0\)\
\-\ subacute\\:\\ 0\\.10735877069665876\ \(0\)\
\-\ male\\:\\ 0\\.10215555954371756\ \(0\)\
\-\ steroids\\:\\ 0\\.100788847650052\ \(0\)\
\-\ radiotracer\\:\\ 0\\.10014005177145871\ \(0\)\
\-\ clinically\\:\\ 0\\.09533571379454829\ \(0\)\
\-\ gland\\:\\ 0\\.09319169308438098\ \(0\)\
\-\ thyroid\\:\\ 0\\.09015624527417852\ \(0\)\
\-\ uptake\\:\\ 0\\.0882129899348599\ \(0\)\
\-\ use\\:\\ 0\\.0877767271001089\ \(0\)\
\-\ pattern\\:\\ 0\\.08564919990350266\ \(0\)\
\-\ cardiac\\:\\ 0\\.08518862416993396\ \(0\)\
\-\ developed\\:\\ 0\\.08511287670546855\ \(0\)\
\-\ treated\\:\\ 0\\.07143941743784066\ \(0\)\
\-\ decreased\\:\\ 0\\.071059954707763\ \(0\)\
\-\ changes\\:\\ 0\\.0693320149326906\ \(0\)\
\-\ if\\:\\ 0\\.0666552004511434\ \(0\)\
\-\ increased\\:\\ 0\\.06203514852774207\ \(0\)\
\-\ with\\:\\ 0\\.044927240381944816\ \(0\)\
\-\ of\\:\\ 0\\.04490041239623724\ \(0\)\
\-\ year\\:\\ 0\\.035354461061625174\ \(0\)\
\-\ for\\:\\ 0\\.034770767006864045\ \(0\)\
\-\ old\\:\\ 0\\.03395252086956811\ \(0\)\
\-\ in\\:\\ 0\\.02853862554162349\ \(0\)\
\-\ and\\:\\ 0\\.02370549401882785\ \(0\)\
\-\ the\\:\\ 0\\.022890807009993405\ \(0\)\
